Synageva Rides Stock Crest, Seeks $100M Public Offering
By Marie Powers
Wednesday, July 11, 2012
Synageva BioPharma Corp. rode the crest of its soaring stock to boost the size of its public offering by 25 percent, from approximately 1.9 million shares cited in its preliminary SEC filing to 2.4 million shares priced at Monday's closing price of $41.20.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.